Delegate Area

Available Video Presentations

In the delegate area PharmaCongress delegates get access to various presentations in advance of the PharmaCongress.

Influence of manufacturing conditions on the surface quality of stainless steels in sensitive industrial applications
Prof. Dr.-Ing.  Arnulf Hörtnagl, in cooperation with Bolz Intec

The ability to form a stable passive layer gives stainless steels their resistance even under aggressive environmental conditions. One aspect that is often neglected is that a stable passive layer also requires adequate pre-treatment. The presentation will explain various influencing factors based on the state of the art. In addition, examples will be given of how the corrosion resistance and also the adhesion behavior of particles can be specifically adapted through the targeted application of manufacturing processes.

Sterile/HPAPI process equipment integration
Stefano Butti, FPS Pharma

Full aseptic production plant integrated into HPAPI isolators. From ANFD discharge of dry powder to delumping by means of integrated conical mill. Secondary step to achieve ultra fine powder generation by integrated spiral Jetmill equipment. In both step it is possible to perform under aspetic condition final dispensing and sampling of milled/micronised product. ATEX certification for equipment EX-proof area installation.

Climate Conditioning of highly toxic APIs. Experience Safety.
Henning Falck, Weiss Pharmatechnik

  • Idea of a Climatic Chamber inside an Isolator
  • Application
  • Challenges for a GMP Compliant Integration
  • Operation

Dual-Mode Isolator System
John Williams, Product Manager, Telstar

  • Merging aseptic and containment modes
  • Flexible design explanation
  • Cost effective approach
  • Pharma equipment industry standards compliance

Risk Assessment in Contamination Control
Arjan Langen, Sterility Assurance Director, GE Healthcare

  • Relevant Guidelines – e.g. ICH Q9, WHO and MHRA
  • Tools for Risk Assessments – FMEA and HACCP
  • Risk Registers – Identify, Evaluate and Communicate Potential Quality Impact
  • Risk Management in Contamination Control

Self-calibrating Temperature Measurement according to FDA and ISPE GAMP
Dietmar Saecker, Senior Product and Application Expert

In the majority of pharmaceutical plants, measuring devices are removed and calibrated at fixed points in time. Since 2011, the US Food and Drug Administration (FDA) and the International Society for Pharmaceutical Engineering (ISPE) Good Automated Manufacturing Practices (GAMP) rules have required continuous process monitoring and advocated risk-based calibration management. With temperature making up a large part of critical measuring devices we present ways to integrate self-calibrating/self-verifying temperature measurement devices into existing plants.

Contamination Control Strategy - Inspector´s View on an Overarching Strategy
Dr Rainer Gnibl, GMP Inspector for EMA and local Government, Germany

  • Requirements
  • Expectations & Interpretations
x